Showing results (861-870 of 1,823) with videos related to
Sort By:
Pageof 183
Transplantation and Cellular Therapy|May 22, 2026
Prolonged Cytokine Release Syndrome Is Associated With Hypofibrinogenemia After CD19-Directed CAR T-Cell Therapy in Adult Patients With Relapsed/Refractory LymphomaSeiya Bamba, Tomoyasu Jo, Toshio Kitawaki, et al.Transplantation and Cellular Therapy|May 24, 2026
Impact of ASTCT toxicity grading system on outcomes after CAR-T for mature B-cell malignanciesMarina Gomez-Llobell, Silvia Escribano Serrat, Maria Bromberg, et al.Transplantation and Cellular Therapy|June 12, 2026
Impact of Acute Graft-Versus-Host Disease and Delayed Hematopoietic Recovery on the Incidence and Clinical Burden of Late Cytomegalovirus Reactivation and Disease After Letermovir Prophylaxis During the First 100 Days After Cord Blood TransplantationNaoki Okada, Hiroyuki Muranushi, Junya Kanda, et al.Transplantation and Cellular Therapy|April 26, 2026
Toward Integrated Psychosocial and Palliative Care in Hematopoietic Stem Cell Transplantation:Models, Gaps, and Practical RecommendationsTimothy S Sannes, Benjamin W Brewer, Lori Wiener, et al.Transplantation and Cellular Therapy|May 11, 2026
Infections in the first 30-days after CAR-T therapy in Patients Not Receiving Fluoroquinolone ProphylaxisGemma K Reynolds, Mark R Dowling, Jose Valencia-Klug, et al.Transplantation and Cellular Therapy|April 22, 2026
Outcomes of Allogeneic Hematopoietic Cell Transplantation for Hypoplastic Myelodysplastic Syndrome: A Latin American Multicenter AnalysisFernando Barroso Duarte, Yhasmine Delles Oliveira Garcia, Maria Cristina Martins de Almeida Macedo, et al.Transplantation and Cellular Therapy|May 5, 2026
Increased susceptibility to long-term complications in leukemia survivors who received hematopoietic stem cell transplantation during adolescenceLéna Pessarossi, Marilyne Poirée, Jean-Hugues Dalle, et al.Transplantation and Cellular Therapy|May 11, 2026
Impact of CD34+ Graft Cell Dose on Outcomes After Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide-Based GVHD ProphylaxisMoazzam Shahzad, Muhammad Kashif Amin, Haritha Gandicheruvu, et al.Transplantation and Cellular Therapy|May 10, 2026
Efficacy of low-dose rituximab as preemptive treatment of EBV DNA-emia after allogeneic hematopoietic stem cell transplantationYi Wang, Yaoyao Shen, Jiaqian Qi, et al.Transplantation and Cellular Therapy|July 31, 2026
Cytokine Release Syndrome and Immune Effector Cell-Associated Neurotoxicity Syndrome Following Axicabtagene Ciloleucel or Brexucabtagene Autoleucel Chimeric Antigen Receptor T-Cell Therapy: Center for International Blood and Marrow Transplant Research DataMatthew J Frigault, Richard T Maziarz, Theresa Amoloja, et al.Pageof 183